Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
癌症患者因 ≥2 级免疫相关不良事件而停用免疫检查点抑制剂后再次使用免疫检查点抑制剂的安全性
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-001622
Allouchery, Marion; Lombard, Thomas; Martin, Mickael; Rouby, Franck; Sassier, Marion; Bertin, Celia; Atzenhoffer, Marina; Miremont-Salame, Ghada; Perault-Pochat, Marie-Christine; Puyade, Mathieu